IXHL
Income statement / Annual
Last year (2026), Incannex Healthcare Inc's total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2026, Incannex Healthcare Inc's net income was -$19.30 M.
See Incannex Healthcare Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2026
|
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
06/30/2026 |
06/30/2025 |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
| Operating Revenue |
$0.00 |
$86.00 K |
$12.00 K |
$0.00 |
$785.15 K |
$1.90 M |
$599.72 K |
$1.18 M |
$1.01 M |
$283.02 K |
| Cost of Revenue |
$240.00 K
|
$246.00 K
|
$103.00 K
|
$0.00
|
$6.34 K
|
$913.26 K
|
$446.50 K
|
$583.19 K
|
$522.83 K
|
$518.28 K
|
| Gross Profit |
-$240.00 K
|
-$160.00 K
|
$12.00 K
|
$0.00
|
$778.79 K
|
$987.02 K
|
$153.22 K
|
$597.26 K
|
$486.99 K
|
-$235.26 K
|
| Gross Profit Ratio |
0
|
-1.86
|
1
|
0
|
0.99
|
0.52
|
0.26
|
0.51
|
0.48
|
-0.83
|
| Research and Development Expenses |
$5.21 M
|
$10.75 M
|
$19.28 M
|
$9.50 M
|
$5.37 M
|
$4.76 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$17.82 M
|
$12.74 M
|
$23.98 M
|
$10.05 M
|
$7.43 M
|
$3.34 M
|
$1.77 M
|
$1.90 M
|
$2.47 M
|
$2.20 M
|
| Selling & Marketing Expenses |
$0.00
|
$390.00 K
|
$1.58 M
|
$1.88 M
|
$2.75 M
|
$4.35 M
|
$402.76 K
|
$706.04 K
|
$1.17 M
|
$552.31 K
|
| Selling, General & Administrative Expenses |
$17.82 M
|
$13.13 M
|
$25.56 M
|
$11.93 M
|
$10.18 M
|
$7.70 M
|
$2.17 M
|
$2.61 M
|
$3.64 M
|
$2.75 M
|
| Other Expenses |
-$240.00 K
|
-$246.00 K
|
-$14.79 M
|
-$895.54 K
|
-$3.42 M
|
-$37.55 K
|
$2.09 M
|
$779.34 K
|
$54.50 K
|
$18.04 M
|
| Operating Expenses |
$22.79 M
|
$23.63 M
|
$30.05 M
|
$20.53 M
|
$12.13 M
|
$12.41 M
|
$4.26 M
|
$3.39 M
|
$3.70 M
|
$20.79 M
|
| Cost And Expenses |
$23.03 M
|
$23.88 M
|
$30.05 M
|
$20.53 M
|
$12.18 M
|
$13.33 M
|
$4.71 M
|
$3.97 M
|
$4.22 M
|
$21.31 M
|
| Interest Income |
$21.00 K
|
$62.00 K
|
$308.40 K
|
$362.73 K
|
$6.27 K
|
$2.68 K
|
$4.50 K
|
$1.63 K
|
$6.84 K
|
$9.46 K
|
| Interest Expense |
$0.00
|
$303.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$85.21 K
|
$12.85 K
|
$49.97 K
|
| Depreciation & Amortization |
$240.00 K
|
$246.00 K
|
$103.00 K
|
$132.45 K
|
$11.35 M
|
$10.19 M
|
$34.78 K
|
$42.53 K
|
$55.01 K
|
$32.29 K
|
| EBITDA |
-$22.79 M |
-$23.54 M |
-$27.75 M |
-$20.39 M |
-$5.19 M |
-$1.24 M |
-$4.08 M |
-$2.75 M |
-$3.14 M |
-$20.99 M |
| EBITDA Ratio |
0
|
-273.76
|
-2312.79
|
0
|
-6.61
|
-0.65
|
-6.8
|
-2.33
|
-3.11
|
-74.15
|
| Operating Income Ratio |
0
|
-276.62
|
-2503.42
|
0
|
-14.46
|
-6.01
|
-6.85
|
-2.37
|
-3.18
|
-74.3
|
| Total Other Income/Expenses Net |
-$933.00 K
|
-$24.85 M
|
$178.00 K
|
-$52.94 M
|
-$3.55 M
|
$38.30 K
|
$215.32 K
|
-$81.77 K
|
$6.73 K
|
-$40.51 K
|
| Income Before Tax |
-$23.96 M
|
-$48.64 M
|
-$18.43 M
|
-$73.47 M
|
-$14.90 M
|
-$11.39 M
|
-$3.90 M
|
-$2.87 M
|
-$3.20 M
|
-$21.07 M
|
| Income Before Tax Ratio |
0
|
-565.59
|
-1535.75
|
0
|
-18.98
|
-5.99
|
-6.5
|
-2.44
|
-3.17
|
-74.44
|
| Income Tax Expense |
-$4.66 M
|
-$1.76 M
|
$30.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$151.58 K
|
-$262.65 K
|
-$305.76 K
|
| Net Income |
-$19.30 M
|
-$46.89 M
|
-$18.46 M
|
-$73.47 M
|
-$14.90 M
|
-$11.39 M
|
-$4.66 M
|
-$2.72 M
|
-$2.94 M
|
-$20.76 M
|
| Net Income Ratio |
0
|
-545.17
|
-1538.25
|
0
|
-18.98
|
-5.99
|
-7.77
|
-2.31
|
-2.91
|
-73.36
|
| EPS |
-1.66 |
-40.8 |
-3.42 |
-14.31 |
-1.5 |
-1.4 |
-0.69 |
-0.74 |
-1.56 |
-19.59 |
| EPS Diluted |
-1.66 |
-40.8 |
-3.42 |
-14.31 |
-1.5 |
-1.4 |
-0.69 |
-0.74 |
-1.56 |
-19.59 |
| Weighted Average Shares Out |
$11.66 M
|
$1.15 M
|
$5.39 M
|
$5.13 M
|
$9.93 M
|
$8.15 M
|
$5.70 M
|
$3.73 M
|
$1.90 M
|
$1.06 M
|
| Weighted Average Shares Out Diluted |
$11.66 M
|
$1.15 M
|
$5.39 M
|
$5.13 M
|
$9.93 M
|
$8.15 M
|
$5.70 M
|
$3.73 M
|
$1.90 M
|
$1.06 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
